American Liver Foundation Launches Spanish-Language Registry
The American Liver Foundation (ALF) has proudly introduced a groundbreaking initiative to benefit individuals with liver diseases by launching the first-ever Spanish-language patient registry for all types of liver conditions. This innovative project is designed to cater to the Hispanic/Latino community, ensuring that their unique experiences and treatment needs are included in vital medical research.
Purpose and Importance of the Registry
The American Liver Foundation Patient Registry serves as an essential resource for researchers aiming to gain insights into various liver diseases. It enhances understanding of existing treatments and their effects on patients’ lives. Understanding that language barriers significantly impact participation in medical research, Lorraine Stiehl, CEO of the American Liver Foundation, emphasizes the need for diverse voices in liver disease studies. This registry is a crucial step in ensuring that Hispanic and Latino communities are included in the conversation about liver health.
User-Friendly Platform
The Spanish-language registry is more than just a simple translation; it has been meticulously crafted by professional translators specializing in medical terminology. This commitment to clarity ensures that patients can easily understand complex healthcare information without losing the context of their conditions. Future treatments and cures will benefit from the rich data gathered through this comprehensive platform powered by EmpiraMed, a leader in digital research technology.
Engaging Diverse Communities
Helene Jordan, National Senior Director of Research Program Management, expresses excitement about this initiative, acknowledging the longstanding challenge of reaching communities impacted by liver disease. The initiative invites people from all walks of life to contribute to the registry, thus fostering a comprehensive understanding of liver disease among varied populations. This participation will ultimately facilitate better research outcomes and solution-oriented strategies.
What Does Participation Entail?
Adults aged 18 years and older in the United States with any form of liver disease are encouraged to join the registry. The participation process is straightforward. Patients complete an online survey that collects information about their liver health history, management, and treatment experiences. This data is invaluable as it not only supports ongoing research but also potentially opens the door to additional research opportunities for participants.
Commitment to Privacy
ALF places a high priority on the privacy and security of participants' information. Personal identifiers such as names or email addresses will not be disclosed. Participants can contribute to improving liver health awareness and treatment options with peace of mind regarding their privacy.
About the American Liver Foundation
The American Liver Foundation operates as a national support system for patients, caregivers, and medical professionals dedicated to liver health improvement. With a mission to empower over 100 million Americans living with liver diseases, they provide essential resources and advocacy for patients and their families. Through educational initiatives and support networks, ALF stands as a crucial ally in the journey toward better liver health.
About EmpiraMed, Inc.
EmpiraMed, a pioneering digital health company, focuses on leveraging real-world evidence to enhance healthcare globally. Their commitment to collecting data through virtual clinical studies enables more informed decisions regarding liver disease management and research advancements. Through partnerships with organizations like ALF, EmpiraMed plays a pivotal role in transforming health outcomes.
Frequently Asked Questions
What is the purpose of the Spanish-language registry?
The registry aims to collect data from Spanish-speaking individuals with liver diseases to enhance research and treatment accessibility for the Hispanic/Latino community.
Who can participate in the registry?
Adults aged 18 and older in the United States with any type of liver disease are eligible to participate in the registry.
How is participant privacy ensured?
The American Liver Foundation commits to maintaining participant confidentiality, ensuring that personal identifiable information remains secure and private.
What kind of information is collected in the registry?
Participants provide details about their liver health history, management practices, treatment regimes, and relevant lifestyle factors through an online survey.
Why is it important to include diverse populations in liver disease research?
Diverse participation in research ensures comprehensive understanding and development of treatments that cater to the unique needs of various communities affected by liver diseases.
